Dybedal I - Search Results

1

Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression.

Dybedal I, Yang L, Bryder D, Aastrand-Grundstrom I, Leandersson K, Jacobsen SE. Dybedal I, et al. Blood. 2003 Jul 1;102(1):118-26. doi: 10.1182/blood-2002-07-2286. Epub 2003 Mar 13. Blood. 2003. PMID: 12637333 Free article.

2

IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor.

Dybedal I, Larsen S, Jacobsen SE. Dybedal I, et al. J Immunol. 1995 May 15;154(10):4950-5. J Immunol. 1995. PMID: 7537295

3

Transforming growth factor beta (TGF-beta), a potent inhibitor of erythropoiesis: neutralizing TGF-beta antibodies show erythropoietin as a potent stimulator of murine burst-forming unit erythroid colony formation in the absence of a burst-promoting activity.

Dybedal I, Jacobsen SE. Dybedal I, et al. Blood. 1995 Aug 1;86(3):949-57. Blood. 1995. PMID: 7542505 Free article.

4

The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells.

Rusten LS, Dybedal I, Blomhoff HK, Blomhoff R, Smeland EB, Jacobsen SE. Rusten LS, et al. Among authors: dybedal i. Blood. 1996 Mar 1;87(5):1728-36. Blood. 1996. PMID: 8634418 Free article.

5

Transforming growth factor-beta1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells.

Dybedal I, Guan F, Borge OJ, Veiby OP, Ramsfjell V, Nagata S, Jacobsen SE. Dybedal I, et al. Blood. 1997 Nov 1;90(9):3395-403. Blood. 1997. PMID: 9345022 Free article.

6

Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells.

Dybedal I, Bryder D, Fossum A, Rusten LS, Jacobsen SE. Dybedal I, et al. Blood. 2001 Sep 15;98(6):1782-91. doi: 10.1182/blood.v98.6.1782. Blood. 2001. PMID: 11535512 Free article.

7

Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation.

Bryder D, Ramsfjell V, Dybedal I, Theilgaard-Mönch K, Högerkorp CM, Adolfsson J, Borge OJ, Jacobsen SE. Bryder D, et al. Among authors: dybedal i. J Exp Med. 2001 Oct 1;194(7):941-52. doi: 10.1084/jem.194.7.941. J Exp Med. 2001. PMID: 11581316 Free PMC article.

8

IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells.

Yang L, Dybedal I, Bryder D, Nilsson L, Sitnicka E, Sasaki Y, Jacobsen SE. Yang L, et al. Among authors: dybedal i. J Immunol. 2005 Jan 15;174(2):752-7. doi: 10.4049/jimmunol.174.2.752. J Immunol. 2005. PMID: 15634895

9

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.

Woll PS, Kjällquist U, Chowdhury O, Doolittle H, Wedge DC, Thongjuea S, Erlandsson R, Ngara M, Anderson K, Deng Q, Mead AJ, Stenson L, Giustacchini A, Duarte S, Giannoulatou E, Taylor S, Karimi M, Scharenberg C, Mortera-Blanco T, Macaulay IC, Clark SA, Dybedal I, Josefsen D, Fenaux P, Hokland P, Holm MS, Cazzola M, Malcovati L, Tauro S, Bowen D, Boultwood J, Pellagatti A, Pimanda JE, Unnikrishnan A, Vyas P, Göhring G, Schlegelberger B, Tobiasson M, Kvalheim G, Constantinescu SN, Nerlov C, Nilsson L, Campbell PJ, Sandberg R, Papaemmanuil E, Hellström-Lindberg E, Linnarsson S, Jacobsen SE. Woll PS, et al. Among authors: dybedal i. Cancer Cell. 2014 Jun 16;25(6):794-808. doi: 10.1016/j.ccr.2014.03.036. Epub 2014 May 15. Cancer Cell. 2014. PMID: 24835589 Free article.

10

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundström L, von Bahr L, Baltzer-Sollander K, Jädersten M, Kytölä S, Walldin G, Ljungman P, Groenbaek K, Mielke S, Jacobsen SEW, Ebeling F, Cavelier L, Smidstrup Friis L, Dybedal I, Hellström-Lindberg E. Tobiasson M, et al. Among authors: dybedal i. J Clin Oncol. 2024 Apr 20;42(12):1378-1390. doi: 10.1200/JCO.23.01159. Epub 2024 Jan 17. J Clin Oncol. 2024. PMID: 38232336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters